Serrated polyp detection rates beyond adenoma detection rate for postcolonoscopy colorectal cancer: findings from the SCREESCO trial
Endoscopy · 16.10.2026
DOI: 10.1055/a-2955-8529 ↗Kurz gefasst
Klinische Studie in der Zeitschrift Endoscopy, erschienen am 16.10.2026. Verfasst von Masau Sekiguchi und 4 weiteren Autor:innen. Beteiligte Einrichtung: National Cancer Center Institute for Cancer Control, Division of Screening Technology, Japan, Tokyo. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Cancer Center Research and Development, Regional Cancer Center Mellansverige, 18 Swedish regions.
Abstract (Originalsprache)
The association between serrated polyp detection rates, including proximal serrated polyp detection rate (PSPDR), and postcolonoscopy colorectal cancer (PCCRC) remains unestablished. We investigated PCCRC incidence and characteristics, and explored associations of PSPDR and adenoma detection rate (ADR) with PCCRC in colonoscopy- and fecal immunochemical test (FIT)-based screening within the Screening of Swedish Colons (SCREESCO) trial. Data from participants who underwent colonoscopy in the colonoscopy and FIT arms were analyzed. PCCRC, defined as colorectal cancer (CRC) diagnosed >6 months after a colonoscopy that did not detect CRC, was identified through linkage with cancer registries. Associations between PSPDR and PCCRC incidence were assessed using Cox models. Of 9982 and 5875 individuals in the colonoscopy and FIT arms, PCCRC was identified in 20 and 17 individuals, with 3-year PCCRC rates of 5.9% (3/51) and 3.5% (4/115), respectively. Compared with screening-detected CRC, PCCRC more often involved right-sided location and advanced stage. The 5-year cumulative incidence of PCCRC was 0.16% (95%CI 0.10%–0.27%) and 0.06% (95%CI 0.02%–0.15%) when colonoscopies were performed by endoscopists with low vs. high PSPDR (
Autor:innen und Institutionen
- National Cancer Center Institute for Cancer Control, Division of Screening Technology, Japan, Tokyo.
- National Cancer Center Hospital, Endoscopy Division/Cancer Screening Center, Japan, Tokyo.
- Uppsala University, Urology, Department of Surgical Sciences, Sweden, Uppsala.
- Stockholm University, Division of Psychobiology and Epidemiology, Department of Psychology, Sweden, Stockholm.
- Karolinska Institute, Division of Neuro, Department of Clinical Neuroscience, Sweden, Stockholm.
- Karolinska Institutet, Department of Medical Epidemiology and Biostatistics, Sweden, Stockholm.
ORCID-Profile: Masau Sekiguchi, Anna M Forsberg
Förderung
- National Cancer Center Research and Development
- Regional Cancer Center Mellansverige
- 18 Swedish regions
- Swedish Cancer Society
- Aleris Research and Development Fund
- Eiken Chemical, Japan
- Stockholm County Council
Zitieren
APA
Sekiguchi, M., Westerberg, M., Andreasson, A., Bozorg, S. R., & Forsberg, A. M. (2026). Serrated polyp detection rates beyond adenoma detection rate for postcolonoscopy colorectal cancer: findings from the SCREESCO trial. Endoscopy. https://doi.org/10.1055/a-2955-8529
Vancouver
Sekiguchi M, Westerberg M, Andreasson A, Bozorg SR, Forsberg AM. Serrated polyp detection rates beyond adenoma detection rate for postcolonoscopy colorectal cancer: findings from the SCREESCO trial. Endoscopy. 2026. doi:10.1055/a-2955-8529
BibTeX
@article{Sekiguchi2026,
author = {Sekiguchi, Masau and Westerberg, Marcus and Andreasson, Anna and Bozorg, Soran R and Forsberg, Anna M},
title = {Serrated polyp detection rates beyond adenoma detection rate for postcolonoscopy colorectal cancer: findings from the SCREESCO trial},
journal = {Endoscopy},
year = {2026},
doi = {10.1055/a-2955-8529}
}
EUVIMED